title: [The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].
abstract: BACKGROUND
  Endometrial cancer (EC) is the second most common gynecologic malignancy worldwide in the peri and postmenopausal period. Most often for the endometrioid variety. In early clinical stages long-term survival is greater than 80%, while in advanced stages it is less than 50%. In our country there is not a standard management between institutions. GICOM collaborative group under the auspice of different institutions have made the following consensus in order to make recommendations for the management of patients with this type of neoplasm.
  
  
  METHODS
  The following recommendations were made by independent professionals in the field of Gynecologic Oncology, questions and statements were based on a comprehensive and systematic review of literature. It took place in the context of a meeting of four days in which a debate was held. These statements are the conclusions reached by agreement of the participant members.
  
  
  RESULTS
  Screening should be performed women at high risk (diabetics, family history of inherited colon cancer, Lynch S. type II). Endometrial thickness in postmenopausal patients is best evaluated by transvaginal US, a thickness greater than or equal to 5 mm must be evaluated. Women taking tamoxifen should be monitored using this method. Abnormal bleeding in the usual main symptom, all post menopausal women with vaginal bleeding should be evaluated. Diagnosis is made by histerescopy-guided biopsy. Magnetic resonance is the best image method as preoperative evaluation. Frozen section evaluates histologic grade, myometrial invasion, cervical and adnexal involvement. Total abdominal hysterectomy, bilateral salpingo oophorectomy, pelvic and para-aortic lymphadenectomy should be performed except in endometrial histology grades 1 and 2, less than 50% invasion of the myometrium without evidence of disease out of the uterus. Omentectomy should be done in histologies other than endometriod. Surgery should be always performed by a Gynecologic Oncologist or Surgical Oncologist, laparoscopy is an alternative, especially in patients with hypertension and diabetes for being less morbid. Adjuvant treatment after surgery includes radiation therapy to the pelvis, brachytherapy, and chemotherapy. Patients with Stages III and IV should have surgery with intention to achieve optimal cytoreduction because of the impact on survival (51 m vs. 14 m), the treatment of recurrence can be with surgery depending on the pattern of relapse, systemic chemotherapy or hormonal therapy. Follow-up of patients is basically clinical in a regular basis.
  
  
  CONCLUSIONS
  Screening programme is only for high risk patients. Multidisciplinary treatment impacts on survival and local control of the disease, including surgery, radiation therapy and chemotherapy, hormonal treatment is reserved to selected cases of recurrence. This is the first attempt of a Mexican Collaborative Group in Gynecology to give recommendations is a special type of neoplasm.
authors.affiliation: Instituto de Enfermedades de la Mama FUCAM, México.
authors.forename: Eva
authors.initials: E
authors.lastname: Ruvalcaba-Limón
authors.forename: David
authors.initials: D
authors.lastname: Cantú-de-León
authors.forename: Eucario
authors.initials: E
authors.lastname: León-Rodríguez
authors.forename: Patricia
authors.initials: P
authors.lastname: Cortés-Esteban
authors.forename: Alberto
authors.initials: A
authors.lastname: Serrano-Olvera
authors.forename: Flavia
authors.initials: F
authors.lastname: Morales-Vásquez
authors.forename: Ricardo
authors.initials: R
authors.lastname: Sosa-Sánchez
authors.forename: Andrés
authors.initials: A
authors.lastname: Poveda-Velasco
authors.forename: Alejandro
authors.initials: A
authors.lastname: Crismatt-Zapata
authors.forename: Antonio
authors.initials: A
authors.lastname: Santillán-Gómez
authors.forename: Carmen
authors.initials: C
authors.lastname: Aguilar-Jiménez
authors.forename: Patricia
authors.initials: P
authors.lastname: Alanís-López
authors.forename: Paulino
authors.initials: P
authors.lastname: Alfaro-Ramírez
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: Alvarez-Avitia
authors.forename: Carlos Eduardo
authors.initials: CE
authors.lastname: Aranda-Flores
authors.forename: José Héctor Reynaldo
authors.initials: JH
authors.lastname: Arias-Ceballos
authors.forename: Oscar
authors.initials: O
authors.lastname: Arrieta-Rodríguez
authors.forename: Eduardo
authors.initials: E
authors.lastname: Barragán-Curiel
authors.forename: Daniel
authors.initials: D
authors.lastname: Botello-Hernández
authors.forename: Rocío
authors.initials: R
authors.lastname: Brom-Valladares
authors.forename: Paula Anel
authors.initials: PA
authors.lastname: Cabrera-Galeana
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Cantón-Romero
authors.forename: Daniel
authors.initials: D
authors.lastname: Capdeville-García
authors.forename: Jesús
authors.initials: J
authors.lastname: Cárdenas-Sánchez
authors.forename: Gerardo
authors.initials: G
authors.lastname: Castorena-Roji
authors.forename: Friedman Rafael
authors.initials: FR
authors.lastname: Cepeda-López
authors.forename: Guadalupe
authors.initials: G
authors.lastname: Cervantes-Sánchez
authors.forename: Lucely de Carmen
authors.initials: Lde C
authors.lastname: Cetina-Pérez
authors.forename: Jaime Alberto
authors.initials: JA
authors.lastname: Coronel-Martínez
authors.forename: Seir Alfonso
authors.initials: SA
authors.lastname: Cortés-Cárdenas
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Cruz-López
authors.forename: Jaime G
authors.initials: JG
authors.lastname: de la Garza-Salazar
authors.forename: Consuelo
authors.initials: C
authors.lastname: Díaz-Romero
authors.forename: Alfonso
authors.initials: A
authors.lastname: Dueñas-González
authors.forename: Aura Erazo
authors.initials: AE
authors.lastname: Valle-Solís
authors.forename: Pedro
authors.initials: P
authors.lastname: Escudero-de los Ríos
authors.forename: Efrén
authors.initials: E
authors.lastname: Flores-Alvarez
authors.forename: Rolando
authors.initials: R
authors.lastname: García-Matus
authors.forename: Raquel
authors.initials: R
authors.lastname: Gerson-Cwilich
authors.forename: Aarón
authors.initials: A
authors.lastname: González-Enciso
authors.forename: César
authors.initials: C
authors.lastname: González-de-León
authors.forename: Alfonso Genaro
authors.initials: AG
authors.lastname: Guevara-Torres
authors.forename: Guillermo Sidney
authors.initials: GS
authors.lastname: Herbert-Núñez
authors.forename: Carlos
authors.initials: C
authors.lastname: Hernández-Hernández
authors.forename: Dulce María
authors.initials: DM
authors.lastname: Hernández-Hernández
authors.forename: David
authors.initials: D
authors.lastname: Isla-Ortiz
authors.forename: Ramiro
authors.initials: R
authors.lastname: Jesús-Sandoval
authors.forename: Carlos
authors.initials: C
authors.lastname: Jiménez-Cervantes
authors.forename: Roberto
authors.initials: R
authors.lastname: Kuri-Exsome
authors.forename: José Luis
authors.initials: JL
authors.lastname: López-Obispo
authors.forename: Antonio
authors.initials: A
authors.lastname: Maffuz-Aziz
authors.forename: Luis Manuel
authors.initials: LM
authors.lastname: Martínez-Barrera
authors.forename: Juan Manuel
authors.initials: JM
authors.lastname: Medina-Castro
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Montalvo-Esquivel
authors.forename: Víctor Hugo
authors.initials: VH
authors.lastname: Mora-Aguilar
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: Morales-Palomares
authors.forename: Andrés
authors.initials: A
authors.lastname: Morán-Mendoza
authors.forename: Gilberto
authors.initials: G
authors.lastname: Morgan-Villela
authors.forename: Aída
authors.initials: A
authors.lastname: Mota-García
authors.forename: David Eduardo
authors.initials: DE
authors.lastname: Muñoz-González
authors.forename: Dino Alberto
authors.initials: DA
authors.lastname: Murillo-Cruz
authors.forename: Arturo
authors.initials: A
authors.lastname: Novoa-Vargas
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Ochoa-Carrillo
authors.forename: Luis Fernando
authors.initials: LF
authors.lastname: Oñate-Ocaña
authors.forename: Andrea
authors.initials: A
authors.lastname: Ortega-Rojo
authors.forename: Alma Georgina
authors.initials: AG
authors.lastname: Palacios-Martínez
authors.forename: Antonio
authors.initials: A
authors.lastname: Palomeque-López
authors.forename: María Delia
authors.initials: MD
authors.lastname: Pérez-Montiel
authors.forename: Félix
authors.initials: F
authors.lastname: Quijano-Castro
authors.forename: Samuel
authors.initials: S
authors.lastname: Rivera-Rivera
authors.forename: Lesbia María
authors.initials: LM
authors.lastname: Rivera-Rubí
authors.forename: Juan Ubaldo
authors.initials: JU
authors.lastname: Robles-Flores
authors.forename: Amelia
authors.initials: A
authors.lastname: Rodríguez-Trejo
authors.forename: Efraín
authors.initials: E
authors.lastname: Salas-Gonzáles
authors.forename: Juan Alejandro
authors.initials: JA
authors.lastname: Silva
authors.forename: Gilberto
authors.initials: G
authors.lastname: Solorza-Luna
authors.forename: Rosalía
authors.initials: R
authors.lastname: Souto-del-Bosque
authors.forename: Laura Leticia
authors.initials: LL
authors.lastname: Tirado-Gómez
authors.forename: Salvador
authors.initials: S
authors.lastname: Torrescano-González
authors.forename: Alfonso
authors.initials: A
authors.lastname: Torres-Lobatón
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Trejo-Durán
authors.forename: Verónica
authors.initials: V
authors.lastname: Villavicencio-Valencia
authors.forename: Dolores
authors.initials: D
authors.lastname: Gallardo-Rincón
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002277:Carcinoma / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003952:Diagnostic Imaging; D016889:Endometrial Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D004965:Estrogen Antagonists / Q000009:adverse effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D010535:Laparoscopy; D008197:Lymph Node Excision; D008403:Mass Screening; D008800:Mexico; D009367:Neoplasm Staging / Q000379:methods; D018714:Radiotherapy, Adjuvant; D012307:Risk Factors; D016879:Salvage Therapy; D013629:Tamoxifen / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents; D004965:Estrogen Antagonists; D004967:Estrogens; D013629:Tamoxifen